… Photo courtesy of Center for iPS Cell Research and Application, … to treat Parkinson's disease. Though researchers have been testing stem cells for many years, this team is trying a new … function. In Parkinson's patients, dopaminergic neurons become damaged and die, reducing dopamine production. In the …

… disease (PD) is diagnosed as a movement disorder, motor deficits are preceded by non-motor features including cognitive, … we will use a novel analytic method called Multicategory Composite Least Squares Classifiers. Using data from … Access to Data and Biospecimens …

… defective proteins or perturb normal pathways in the brain. To determine how these alterations lead to disease, it is … genes for tagging based on their relevance to PD, whether commercial antibodies are available for detecting their … sensitive system for detecting the tags, we will find out where these proteins are localized in brain cells — and …

… This year, in a partisan environment, Congress came together to pass historic bipartisan legislation with the … mounts into a public health and economic crisis, it has become ripe for urgent intervention and public-private … than we’ve ever been, bringing unprecedented clarity to where strategic partnership can yield the fastest gains.   …

… Born and raised in Colombia, Diana Rodriguez, age 39, moved to Canada as a teenager. Now a business coach and dedicated … diagnosis of Parkinson’s disease, Diana's passions have become more challenging. Diana’s first sign of Parkinson’s was … grateful for the ability I had to stay proactive and not get paralyzed or scared as I educated myself on …

… Today,  "Forbes" published a story detailing a "milestone … Denali Therapeutics -- a San Francisco-based biotech -- presented data from its  Phase I LRRK2  trial to more than … Fox Foundation stepped in." MJFF brought together three competing companies developing LRRK2 drugs for Parkinson's …